An observational study in Cardiac Arrest, Out-Of-Hospital, sponsored by University Hospital Ostrava. Recruiting at 2 sites in Czechia. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-01-15.
Sponsored by University Hospital Ostrava · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Out-of-Hospital Cardiac Arrest with a site in Czechia — 5 open to participants now, 5 under way, none of them phase 3. Out-of-Hospital Cardiac Arrest · Czechia.
Among the 10 studies in Out-of-Hospital Cardiac Arrest with a site in Czechia, this one is one of 3 that started in 2025, is one of 4 observational ones, and was the 7th registered.
314 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 93 are open to participants now.
Browse Out-of-Hospital Cardiac Arrest studies →5 of the 10 studies in Out-of-Hospital Cardiac Arrest with a site in Czechia are open now. Recruiting first, the newest first:
Emergency Medical Service, Prague · Sites in Czechia
Ages 18–70
University Hospital Ostrava · Sites in Czechia
Ages 18–70
University Hospital Ostrava · Sites in Czechia
Ages 3–60
General University Hospital, Prague · Sites in Czechia
Ages 18–70
A study can be open while its sites in Czechia have not opened yet or have stopped. Only those recruiting at a site in Czechia →
Of the 66 Out-of-Hospital Cardiac Arrest studies recruiting now, 46 (70%) set no upper age limit and 13 (20%) stop at 75 or younger; 8 take children under 18; 7 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 3 started in 2025.
This study's planned enrollment of 100 is below the median of 300 across 128 observational studies indexed under Out-of-Hospital Cardiac Arrest.
Median enrollment 173 across the 6 interventional studies, 87 across the 4 observational. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 10 has an industry lead sponsor. The 7 most frequent:
University Hospital Ostrava is the lead sponsor of 149 studies on the registry; 51 are open to participants now.
University Hospital Ostrava has 4 studies filed under Out-of-Hospital Cardiac Arrest — fewer than ten, so there is no comparison to draw.
1 of the studies in Out-of-Hospital Cardiac Arrest with a site in Czechia that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07596446Emergency Medical Service, PragueFEMART-1 Pilot Study | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Out-of-Hospital Cardiac Arrest with a site in Czechia, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Cardiopulmonary resuscitation (CPR) for out-of-hospital cardiac arrest (OHCA) in specific cases could be improved by Extracorporeal membrane oxygenation (ECMO; ECPR). ECPR could be introduced in hospital after retrieval of an OHCA patient and also faster by implantation on scene. The aim is to verify the effectiveness of ECPR on scene in the Moravian-Silesian region.
Patients undergoing cardiopulmonary resuscitation (CPR) for out-of-hospital cardiac arrest (OHCA) have a poor prognosis and a good long-term neurological outcome is achieved in about 10% of them. Extracorporeal membrane oxygenation (ECMO) can lead to an improvement in neurological outcome of up to 30% in a selected group of these critically ill patients. CPR for OHCA using ECMO in the hospital after patient admission (ECPR) is very demanding and depends on the best collaboration of pre-hospital care components with the hospital management. As good as the coordination of the different phases of care and transport is, patients often arrive to the hospital relatively late (over 60 minutes), and although the process of diagnosis and indication and ECMO implantation itself is rapid (approximately 15 minutes), the overall time from collapse to ECMO initiation is relatively long (over 60 minutes). It is this time, i.e. the duration of low organ perfusion during CPR, that may be the key parameter in determining the overall neurological outcome of treatment and prognosis of patients. Shortening this interval by having the ECMO team go to well-defined OHCA cases simultaneously with the ambulance car of the Emergency Department and connecting the patient to ECMO already in the field may lead to an improvement in the neurological outcome of the treatment of OHCA patients. In many locations abroad, this model is already used, and patients are connected to ECMO already in the field. Whether the model of field ECPR can be used in the Moravian-Silesian Region depends on a number of variables. These include the logic of information acquisition and selection of suitable patients, the logic of transporting the team and material to the scene, and the logic of connection with the provision of a safe and suitable environment for the ECMO implantation itself. The goal of this study is to validate the feasibility of the method on a simulated ECPR OHCA and further implant the mobile ECPR project in the Moravian-Silesian region.
Patients after out-of-hospital cardiac arrest
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with out-of-hospital cardiac arrest indicated for ECMO
Procedure: Extracorporeal membrane oxygenation (ECMO)
In extracorporeal membrane oxygenation (ECMO), blood is pumped outside of the body to a heart-lung machine. The machine removes carbon dioxide and sends oxygen-rich blood back to the body. Blood flows from the right side of the heart to the heart-lung machine. It's then rewarmed and sent back to the body.
Time from cardiac arrest (collapse) to implantation of ECMO
The time from cardiac arrest (collapse) to implantation of ECMO will be recorded and assessed
Time frame: up to 60 minutes
Hospital mortality
Hospital mortality will be assessed for the period of 3 weeks
Time frame: up to 3 weeks
Cerebral Performance Category (CPC) score
Cerebral Performance Category (CPC) score will be observed 30 days after cardiac arrest
Time frame: 30 days
Neurological outcome (CPC score)
Neurological outcome will be assessed using the Cerebral Performance Category Scale (CPC) 6 months after cardiac arrest.
Time frame: 6 months
Neurological outcome (SF-36)
Neurological outcome will be assessed using the Short Form 36 Health Subject Questionnaire (SF-36) 6 months after cardiac arrest.
Time frame: 6 months
Neurological outcome (EQ-5D)
Neurological outcome will be assessed using the European Quality of Life Questionnaire (EQ-5D) 6 months after cardiac arrest.
Time frame: 6 months
Plan to share: No — There is no plan to make individual participant data available to other researchers. The data may be provided upon request.
No publications or documents are linked to this record.
Started Jun 2025 (actual). Primary completion is estimated for Dec 2028, 42 months after the start.
Of 69 non-industry observational studies under Out-of-Hospital Cardiac Arrest, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 75. This study's planned 42 months is close to that.
Counting every sponsor, half of 69 studies reached it within 46 months; a quarter within 20 and three quarters within 75.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Out-of-Hospital Cardiac Arrest →